GHK-Cu — The Copper Tripeptide for Skin and Tissue Research

Category: Peptide Profiles · Updated for 2026 · Reviewed by the Axion Research Peptides scientific team.

Frequently Asked Questions

What is the GHK-Cu peptide?

The GHK-Cu peptide is a copper-binding tripeptide composed of glycine, L-histidine, and L-lysine complexed with a copper(II) ion. It occurs naturally in human plasma, saliva, and urine. In laboratory studies it is investigated as a signaling molecule that modulates extracellular matrix turnover, collagen deposition, angiogenesis, and gene expression in fibroblasts, keratinocytes, and other cell types relevant to wound healing and tissue regeneration.

How does GHK-Cu differ from plain GHK?

GHK is the bare tripeptide sequence Gly-His-Lys. GHK-Cu is the same sequence chelated to a copper(II) cation, forming a 1:1 metal complex with a square-planar coordination geometry. The copper ion is biologically essential to most of GHK’s classical activities: redox signaling, lysyl oxidase activation, and superoxide dismutase-like behavior all depend on the copper center. Most peer-reviewed activity data references the copper complex specifically.

What does GHK-Cu do at the molecular level?

In cultured cells, GHK-Cu binds to copper transport proteins, donates copper to ceruloplasmin and cuproenzymes, and triggers downstream transcriptional changes. Microarray analyses report modulation of more than 4,000 human genes, including upregulation of antioxidant defense, DNA-repair, and matrix-synthesis pathways and downregulation of inflammatory and pro-fibrotic pathways. It also stimulates fibroblast proliferation, collagen and glycosaminoglycan synthesis, and decorin expression.

Is the GHK-Cu peptide approved for human use?

No. GHK-Cu has not been approved by the FDA, EMA, or other regulators as a drug for any indication. It appears as an ingredient in some cosmetic preparations, where claims are limited to topical appearance. All discussion in this profile refers strictly to in vitro and animal research models. The compound supplied by Axion Research Peptides is for laboratory research use only.

How is GHK-Cu typically reconstituted in the lab?

Researchers usually dissolve lyophilized GHK-Cu in bacteriostatic or sterile water, sometimes buffered with acetate or phosphate, taking care to avoid strong reducing agents that disrupt the copper complex. Concentrations of 1-5 mg/mL are common stock ranges. See the Axion peptide reconstitution lab protocol for general technique guidance.

How does GHK-Cu compare with BPC-157 and TB-500?

BPC-157 and TB-500 are larger peptides studied primarily for systemic tissue repair, tendon, ligament, and gastrointestinal healing models. GHK-Cu is a smaller copper-carrying signaling molecule with strong literature in skin, hair follicle, and dermal extracellular matrix research. The compounds are mechanistically distinct and are often studied in parallel rather than as substitutes. See the dedicated BPC-157 research guide and TB-500 research guide for comparison.

What exposure conditions appear in the literature?

Published in vitro and animal studies report a wide range of exposure conditions, including topical applications and parenteral routes in rodents. These figures describe animal and in vitro work only and have no implication for human use. Experimental designs must be developed by qualified researchers under institutional review.

Where can researchers source high-purity GHK-Cu?

Axion Research Peptides supplies pharmaceutical-grade GHK-Cu and a formulated copper peptide blend, Glow, intended for in vitro and preclinical research. Each lot is documented with HPLC purity, mass spectrometry, and endotoxin data. Researchers can order vials at /products/ghk-cu with full certificate of analysis on request.

1. Introduction: Why the GHK-Cu Peptide Matters

Few small molecules have attracted as sustained an interest from skin biology, regenerative medicine, and gerontology researchers as the GHK-Cu peptide. First isolated by Loren Pickart in 1973 from human plasma as a plasma factor studied for its effects on hepatocyte behavior, the glycyl-L-histidyl-L-lysine sequence and its copper complex have become a workhorse tool for studying tissue regeneration, extracellular matrix remodeling, and copper-dependent signaling. The GHK-Cu peptide is now one of the most cited copper peptide research subjects, with literature spanning fibroblast biology, hair follicle science, neural regeneration, lung fibrosis models, and gene expression profiling.

For researchers building a regenerative peptide toolkit, the GHK-Cu peptide complements other tissue-repair candidates such as BPC-157, TB-500, and the anti-inflammatory tripeptide KPV. Where BPC-157 and TB-500 dominate the tendon, vascular, and gastrointestinal repair literature, GHK-Cu carries the strongest signal in dermal and matrix-remodeling assays. This profile reviews the chemistry, mechanisms, peer-reviewed findings, structure-activity relationships, and laboratory handling considerations relevant to investigators planning new copper peptide research.

1.1 Scope and disclaimer of this profile

This article summarizes published in vitro and animal data on the GHK-Cu peptide for the purpose of informing laboratory research design. It is not medical advice and does not endorse any human use. All doses, concentrations, and outcomes described relate to research models. Investigators must follow their institutional review boards, biosafety committees, and applicable laws.

2. Chemistry and Structure of GHK-Cu

GHK-Cu is the copper(II) chelate of the tripeptide glycyl-L-histidyl-L-lysine. The free peptide has the sequence H-Gly-His-Lys-OH, a molecular formula of C₁₄H₂₄N₆O₄, and a molecular weight of approximately 340.4 g/mol. When complexed with one Cu(II) ion, the molecular weight of GHK-Cu rises to roughly 403.9 g/mol (sometimes reported with associated counter-ions and waters of hydration).

2.1 Coordination chemistry

The copper ion is coordinated in a square-planar geometry by the alpha-amino nitrogen of glycine, the deprotonated peptide nitrogen of the Gly-His amide bond, and the imidazole nitrogen of histidine. A fourth coordination site is variable, often occupied by a water molecule, hydroxide, or the carboxylate of a neighboring residue depending on pH and counter-ions. This coordination motif provides a redox-buffered copper environment, allowing the complex to deliver copper to cuproenzymes without generating uncontrolled oxidative damage.

2.2 Stability and pH considerations

The peptide-copper complex is most stable in slightly acidic to neutral pH (approximately 5.5-7.4). Strong reducing agents such as ascorbate at high concentrations, EDTA, and certain thiols can displace the copper and abolish activity. Researchers reconstituting GHK-Cu must therefore avoid contamination with chelators and store the complex in copper-compatible buffers. See the peptide reconstitution lab protocol for general best practices on peptide handling.

2.3 Endogenous and dietary occurrence

GHK is liberated endogenously through proteolysis of larger collagenous proteins, particularly SPARC (osteonectin) and certain forms of alpha-2-HS-glycoprotein. Plasma concentrations of GHK are reported to be roughly 200 ng/mL in young adults and to decline substantially with age. This age-dependent decline forms part of the rationale for studying exogenous GHK-Cu in regenerative models.

3. Mechanism of Action

The GHK-Cu peptide acts as a multifunctional signaling molecule. Rather than binding to a single cell-surface receptor, it appears to influence cellular behavior through several converging mechanisms: copper delivery to cuproenzymes, modulation of redox state, direct binding to extracellular matrix components, and broad transcriptional reprogramming. Together, these mechanisms underpin its prominence in copper peptide research.

3.1 Copper delivery and cuproenzyme activation

GHK-Cu serves as a physiological carrier that delivers copper to enzymes including lysyl oxidase, superoxide dismutase 1 (SOD1), and dopamine-beta-hydroxylase. Lysyl oxidase, for example, requires copper as a cofactor to crosslink collagen and elastin fibers, supporting the GHK-Cu collagen synthesis phenotype seen in fibroblast cultures. By providing copper in a chelated, low-toxicity form, GHK-Cu allows researchers to dissect copper-dependent processes without the artifacts of free Cu²⁺ exposure.

3.2 Antioxidant and anti-inflammatory effects

Several studies report that GHK-Cu mimics superoxide dismutase activity in vitro, neutralizing reactive oxygen species and quenching iron-driven lipid peroxidation. It also down-modulates pro-inflammatory cytokines such as TNF-alpha and IL-6 in cell models and limits NF-kappaB activation under oxidative challenge. These properties contribute to its observed protective effects in GHK-Cu wound healing assays.

3.3 Gene expression and the genomic signature

A landmark microarray study by Pickart and colleagues reported that 1 nM to 1 microM GHK-Cu modulated the expression of approximately 31.2% of measured human genes in cultured cells. The GHK-Cu gene expression signature includes upregulation of DNA repair (such as ERCC2, ERCC4, and several MMR genes), TGF-beta signaling, antioxidant response (NRF2 pathway), and matrix synthesis, with reciprocal downregulation of inflammatory mediators and certain pro-fibrotic genes. Interested investigators can explore the underlying data in the PubMed search for GHK-Cu gene expression.

3.4 Extracellular matrix remodeling

In dermal fibroblast cultures, GHK-Cu stimulates synthesis of type I collagen, glycosaminoglycans, decorin, and elastin, while modulating the activity of matrix metalloproteinases (MMP-2 in particular) and their tissue inhibitors (TIMPs). The reported net effect is organized matrix renewal rather than scar formation in these models, which is one reason GHK-Cu is so heavily studied in skin biology.

4. GHK-Cu Wound Healing Research

GHK-Cu wound healing studies form the historical core of the peptide’s literature. Early investigations in rodents reported effects of topical or subcutaneous administration on closure of full-thickness wounds, tensile strength of granulation tissue, and angiogenesis at the wound margin. More recent work has extended these findings to diabetic, irradiated, and ischemic wound models.

4.1 Acute wound models

In Sprague-Dawley rats with standardized full-thickness wounds, topical GHK-Cu in a saline vehicle has been examined for effects on re-epithelialization, collagen fiber organization, and mast cell and macrophage infiltration. Wound contraction rates are typically compared against vehicle controls. Investigators can survey these data through the GHK-Cu wound healing PubMed corpus.

4.2 Diabetic and ischemic wound models

Diabetic db/db mice display delayed wound closure tied to impaired angiogenesis and excess inflammation. Preclinical reports describe effects of GHK-Cu on these phenotypes, including VEGF expression and endothelial sprouting. Similar effects have been observed in ischemic flap models. While intriguing, all such results remain confined to animal data and are not translatable to human therapy without controlled clinical trials.

4.3 Comparative regenerative peptides

Investigators comparing GHK-Cu against other regenerative peptides often pair it with BPC-157 and TB-500 to study complementary mechanisms. BPC-157’s gastric-pentadecapeptide chemistry and angiogenic effects, TB-500’s actin-binding profile, and GHK-Cu’s matrix and redox profile each illuminate a different angle of repair. See the top 10 peptides for tissue regeneration overview for comparative context.

5. GHK-Cu Skin Regeneration and Dermal Aging

The GHK-Cu skin regeneration literature is extensive, ranging from controlled in vitro studies on cultured fibroblasts to ex vivo skin models. Three endpoints recur: collagen and decorin production, dermal architecture in aged or photodamaged skin models, and markers of oxidative stress.

5.1 Collagen, elastin, and decorin

Cultured human dermal fibroblasts treated with low-nanomolar to low-micromolar GHK-Cu typically show increased production of type I collagen, elastin, and decorin. Decorin is particularly notable because it organizes collagen fibrils into ordered, scar-free arrays. The combination of upregulated matrix synthesis and increased lysyl oxidase activity supports a phenotype of organized matrix renewal.

5.2 Photoaging and barrier function

Photoaging models exposed to chronic UV-A and UV-B irradiation display thinning of the dermis, fragmentation of collagen, and accumulation of damaged elastin (solar elastosis). Preclinical data suggest GHK-Cu can counteract several of these markers, partly by activating the NRF2 antioxidant response and partly by directly stimulating matrix synthesis. Authoritative background on dermal aging can be found at the NCBI literature portal.

5.3 Hair follicle research

Beyond the dermis itself, GHK-Cu has been studied in hair follicle cultures, where it has been examined for effects on anagen-phase markers, dermal papilla signaling, and follicle size in mouse models, making GHK-Cu a tool compound in follicle biology.

5.4 Formulation considerations for in vitro skin models

Investigators using ex vivo skin equivalents and reconstructed epidermis models commonly apply GHK-Cu in aqueous or mildly buffered vehicles, sometimes within polymer or liposomal carriers to test delivery. The formulated peptide blend Glow illustrates a research-grade composition combining GHK-Cu with complementary regenerative peptides for use in such models.

6. GHK-Cu Gene Expression — A Closer Look

One of the most cited features of GHK-Cu is its remarkably broad effect on transcriptional programs. The GHK-Cu gene expression signature has been profiled in fibroblasts, neuronal cells, and lung cells, with consistent themes emerging across cell types.

6.1 The 4,000-gene signature

Using the Broad Institute’s Connectivity Map platform, investigators have reported that GHK-Cu modulates the expression of more than 4,000 human genes by more than 50% from baseline at low-nanomolar concentrations. The signature includes upregulation of DNA repair genes (such as MSH2, MSH6, and ERCC pathway members), antioxidant defense (HMOX1, NQO1, NRF2 targets), and matrix synthesis pathways. The PubMed record for these analyses is accessible via this PubMed search.

6.2 Pathway implications

The gene-expression data implicate GHK-Cu in DNA damage response, mitochondrial biogenesis, ubiquitin-proteasome regulation, and TGF-beta signaling. These pathways are central not only to wound healing but to a range of regenerative and gerontological hypotheses. In COPD lung-cell models, for example, GHK-Cu was reported to alter disease-associated gene expression patterns, leading investigators to propose mechanistic links between copper homeostasis and pulmonary aging.

6.3 Cautions in interpreting the signature

The breadth of the gene expression signature is striking but also raises caveats. Effects are dose- and cell-type-dependent, and Connectivity Map analyses primarily highlight transcriptional similarity, not phenotypic equivalence. Investigators should treat the 4,000-gene number as a heuristic for the compound’s reach rather than as a precise pharmacodynamic readout.

7. Comparative Data Table

The following table summarizes commonly cited research-grade parameters for the GHK-Cu peptide alongside other regenerative peptides offered by Axion Research Peptides. Values are illustrative and drawn from peer-reviewed literature for in vitro and animal models only.

8. Structure-Activity Relationships

Detailed structure-activity work has clarified which elements of the GHK-Cu peptide are required for its diverse activities. Researchers designing analogs or planning mechanistic studies will find this background useful when selecting controls.

8.1 The histidine imidazole

Replacement of histidine in the GHK sequence abolishes high-affinity copper binding and most downstream activity. The imidazole nitrogen is essential for the square-planar Cu(II) coordination geometry that defines the complex.

8.2 The lysine side chain

The free amino group on lysine contributes to electrostatic interactions with extracellular matrix components such as heparan sulfate proteoglycans. Acetylation or further modification of lysine alters tissue binding and pharmacokinetic profile. Some derivatives, including palmitoylated tripeptide variants, are designed to enhance lipid-bilayer permeation.

8.3 Free versus chelated peptide

Investigators sometimes compare GHK alone with GHK-Cu to dissect copper-dependent from copper-independent effects. The copper-free peptide retains some matrix-modulating activity but loses most antioxidant, lysyl oxidase, and gene-expression signatures. The Cu(II) complex is therefore the standard reference compound in copper peptide research.

8.4 Analogs and conjugates

Several analogs have been reported, including palmitoyl-tripeptide-1, palmitoyl-tetrapeptide-7, and longer copper-binding sequences such as AHK-Cu. None has matched the published breadth of GHK-Cu’s transcriptional and regenerative profile, although they remain useful comparator compounds.

9. Laboratory Handling, Reconstitution, and Storage

Practical handling of the GHK-Cu peptide is straightforward but requires attention to the copper complex’s specific chemistry. The notes below complement the general peptide reconstitution lab protocol.

9.1 Reconstitution

Lyophilized GHK-Cu is typically reconstituted in sterile or bacteriostatic water at 1-5 mg/mL. Solutions may have a faint blue tint owing to the Cu(II) chromophore. Avoid reconstitution in buffers containing EDTA, DTPA, citrate at high concentrations, or strong thiol reducing agents. Mildly acidic acetate or neutral phosphate buffers compatible with copper are acceptable.

9.2 Storage and stability

Unreconstituted GHK-Cu should be stored desiccated at -20 degrees Celsius and protected from light. Reconstituted solutions are typically stable for 2-4 weeks at 2-8 degrees Celsius when kept sterile, though investigators should verify stability for their own experimental conditions. Repeated freeze-thaw cycles should be avoided.

9.3 In vitro working solutions

Working solutions for cell culture are usually prepared by diluting stock into serum-containing or serum-free media to final concentrations of 1 nM to 10 microM. Investigators should account for copper-binding components in media (such as ceruloplasmin in serum) that may alter free-versus-bound peptide ratios.

9.4 Animal model considerations

Rodent wound and dermal models have used both topical and parenteral exposure routes; investigators should take specific parameters from the primary literature. These are research-model facts only and do not extend to human use of any kind.

10. Safety, Toxicology, and Regulatory Status

GHK-Cu has a favorable toxicology profile in published animal studies, reflecting both its endogenous origin and the controlled redox state of its copper center.

10.1 Acute and subchronic toxicity

10.2 Local tolerance

Topical formulations of GHK-Cu have been studied in cosmetic safety assessments and generally show low irritation potential at concentrations below 2%. Higher concentrations or certain vehicle systems may produce transient erythema in sensitive subjects.

10.3 Regulatory status

GHK-Cu is not approved as a drug by the U.S. Food and Drug Administration, the European Medicines Agency, or other major regulators. It is used as a cosmetic ingredient and as a laboratory research compound. Investigators should consult ClinicalTrials.gov for any registered exploratory studies and confirm local regulations governing peptide research.

11. Selected Citations and Further Reading

The following references and search portals are useful starting points for further reading. Where a precise PMID has not been independently verified, the link is to a topical PubMed search rather than a specific identifier.

• Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci, 2018. PubMed search.
• Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Res Int, 2015. PubMed search.
• Maquart FX et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett, 1988. PubMed search.
• Simeon A et al. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex. J Invest Dermatol, 2000. PubMed search.
• Hong Y et al. Insight into the mechanism of action of the bioactive peptide GHK-Cu in COPD-related gene expression. Genome Med, 2012. PubMed search.
• Pickart L. The human tripeptide GHK and tissue remodeling. J Biomater Sci Polym Ed, 2008. PubMed search.
• Pyo HK et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res, 2007. PubMed search.
• Cebrian J et al. Topical GHK-Cu in photoaging models. J Cosmet Sci. PubMed search.
• Park JR et al. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget, 2016. PubMed search.
• Beretta G et al. Copper(II)-glycyl-L-histidyl-L-lysine: oxidative and antioxidative properties. J Inorg Biochem. PubMed search.
• Pickart L et al. GHK and DNA: resetting the human genome to health. Biomed Res Int, 2014. PubMed search.
• Comprehensive entry on GHK biology at Wikipedia: GHK-Cu (definitional reference only).

12. Practical Research Protocols Using GHK-Cu

This section outlines example experimental designs that researchers commonly use when studying the GHK-Cu peptide. They are illustrative; investigators must adapt them to their own scientific questions, models, and review-board requirements.

12.1 Fibroblast collagen assay

Plate primary human dermal fibroblasts at 1 x 10^4 cells per well in 24-well plates. After 24 hours, replace medium with serum-reduced medium containing GHK-Cu at 1 nM, 10 nM, 100 nM, and 1 microM, with vehicle control. After 72 hours, quantify type I collagen by ELISA or Sirius Red staining and confirm cell viability by MTT or CellTiter-Glo. Include AHK-Cu and GHK alone as comparator and copper-control conditions.

12.2 In vitro scratch wound assay

Use a confluent monolayer of HaCaT keratinocytes or dermal fibroblasts. Create a uniform scratch with a sterile pipette tip. Add medium containing GHK-Cu at 10 nM-1 microM. Image wound area at 0, 6, 12, and 24 hours and quantify percent closure. Compare against BPC-157 and TB-500 conditions for parallel context.

12.3 Rodent dermal wound model

Following institutional approval, create standardized full-thickness wounds on the dorsum of anesthetized mice or rats. Apply daily topical GHK-Cu at 0.05-1% in a saline or hydrogel vehicle, alongside vehicle-only controls. Measure wound area planimetrically and harvest tissue for histology, Masson’s trichrome staining, and immunohistochemistry of CD31 and Ki-67 at defined endpoints.

12.4 Transcriptomic profiling

For investigators interested in the GHK-Cu gene expression signature, RNA-seq of fibroblasts or keratinocytes treated with 10 nM and 1 microM GHK-Cu for 6 and 24 hours, with matched vehicle controls, captures both early and sustained transcriptional responses. Pathway enrichment analyses typically highlight matrix synthesis, NRF2 targets, and DNA repair categories.

13. Key Takeaways

• The GHK-Cu peptide is a naturally occurring copper-binding tripeptide central to a large body of copper peptide research.
• Its mechanism of action combines copper delivery, antioxidant activity, and broad modulation of gene expression, with more than 4,000 human genes affected at low concentrations.
• GHK-Cu wound studies in rodents report closure, tensile-strength, and angiogenesis endpoints.
• GHK-Cu collagen synthesis effects in dermal fibroblasts include upregulation of type I collagen, decorin, and elastin.
• GHK-Cu skin regeneration data extend to photoaging models, hair follicle biology, and reconstructed epidermis systems.
• Comparative data position the compound as complementary to BPC-157, TB-500, and KPV in regenerative peptide toolkits.
• The compound is not approved for human use and is offered strictly for laboratory research.

14. Conclusion

The GHK-Cu peptide remains one of the most thoroughly characterized small molecules in regenerative biology, with decades of literature spanning fibroblast cultures, wound models, hair follicle research, and Connectivity Map-scale transcriptomics. Its convergent mechanisms in copper transport, redox regulation, matrix synthesis, and gene expression make it a uniquely versatile tool compound for investigators in skin biology, gerontology, and tissue engineering. For laboratories building a comprehensive regenerative peptide program, the GHK-Cu peptide is a foundational reagent that complements peptides such as BPC-157, TB-500, and KPV.

Related research from Axion

• BPC-157 research guide
• TB-500 research guide
• Top 10 peptides for tissue regeneration
• Peptide reconstitution lab protocol

Disclaimer: These products are sold strictly for laboratory research purposes only. Not for human consumption, diagnosis, or treatment. Statements have not been evaluated by the FDA, EMA, or any regulatory agency. Researchers must comply with all applicable laws and institutional review requirements.